Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Related Posts David Morgan: Silver’s Rubicon Moment? US$50 in Sight, but Watch for Shakeout October 7, 2025 Gold Price Breaks US$3,900; Silver Above US$48, Platinum Over US$1,600 October 7, 2025 Syntheia Announces Closing of the Final Tranche of Private Placement October 7, 2025